Multisite Validation of a Venous Thrombosis Risk Model in Critically Ill Children Through the CHAT Consortium

医学 接收机工作特性 风险评估 急诊医学 静脉血栓形成 病危 弗雷明翰风险评分 静脉血栓栓塞 重症监护室 队列 重症监护医学 血栓形成 队列研究 儿科 前瞻性队列研究 重症监护 预警得分 病历 梅德林 校准 回顾性队列研究 疾病严重程度 金标准(测试) 试验预测值 临床试验 儿科重症监护室 肺栓塞 试验前后概率 死亡风险
作者
Julie Jaffray,Brian R. Branchford,Maua Mosha Alleyne,Ernest Amankwah,E. Vincent S. Faustino,Neil A. Zakai,Anthony A. Sochet,Amy Stillings,Emily Krava,Guy Young,Neil A. Goldenberg
出处
期刊:Blood [Elsevier BV]
标识
DOI:10.1182/blood.2025029841
摘要

Critically ill children have a high risk of hospital associated venous thromboembolism (HA-VTE). Developing a validated risk assessment model (RAM) to identify children who may benefit from thromboprophylaxis is essential. We aimed to prospectively validate the Children's Healthcare Advancements in Thrombosis (CHAT) intensive care unit (ICU) VTE RAM containing five clinically significant variables: CVC, immobility, congenital heart disease, autoimmune or inflammatory conditions and hospital stay of ≥3 days in a multicenter cohort study. Randomly selected patients aged 0-21 years admitted to a pediatric ICU (PICU) at 32 institutions were monitored via medical record review for HA-VTE. Discrimination was assessed using the area under the receiver operating characteristic (AUROC) curve. Calibration was assessed using calibration plots. Complete case and imputed analyses were performed and model risk scores were generated along with post-test probability. The RAM was validated in 4,674 patients with an AUROC of 0.71 [95% CI:0.64-0.78], calibration slope of 1.0 (95% CI:0.87-1.14) and intercept of 1.81x10-5 (95% CI: -5.40x10-3-5.44x10- 3). The AUROC for the imputed model was 0.69 (95% CI:0.68-0.70) with the calibration slope of 1.03 (95% CI: 0.85-1.21) and intercept of 1.22x10-3 (95% CI: -7.80x10-3-5.36x10-3). Calculated risk scores were 1 or 2 for each variable in the RAM with a total risk score ranging from 0 to 6. The estimated probability for developing HA-VTE ranged from 1% to 17.4% depending on the total score. In conclusion, the CHAT-ICU RAM has good discriminatory validity, is well-calibrated and reliably identifies children in the PICU at high and low risk of HA-VTE.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Husleo发布了新的文献求助10
1秒前
2秒前
是你发布了新的文献求助20
3秒前
NNi发布了新的文献求助10
4秒前
4秒前
华仔应助伟卫采纳,获得10
4秒前
4秒前
kim完成签到,获得积分10
6秒前
Zeus发布了新的文献求助10
7秒前
7秒前
玉耀完成签到,获得积分10
8秒前
Frank发布了新的文献求助10
8秒前
马嘉祺发布了新的文献求助10
9秒前
年轻纸飞机完成签到 ,获得积分10
9秒前
11秒前
科研通AI6.3应助刘欢采纳,获得10
12秒前
13秒前
13秒前
鑫001发布了新的文献求助10
13秒前
13秒前
简单盛男完成签到,获得积分10
14秒前
ttzi完成签到 ,获得积分10
15秒前
16秒前
爆米花应助迷路的立辉采纳,获得10
17秒前
aaaa发布了新的文献求助20
17秒前
王姗and帅白完成签到,获得积分10
18秒前
Zeus完成签到,获得积分10
19秒前
西海焖面完成签到,获得积分10
19秒前
称心凡发布了新的文献求助10
21秒前
怡然的怀绿完成签到,获得积分10
21秒前
huangdq6完成签到 ,获得积分10
22秒前
arniu2008应助Jerry采纳,获得20
22秒前
24秒前
25秒前
25秒前
25秒前
qq完成签到 ,获得积分10
26秒前
28秒前
29秒前
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Trees of tropical Asia : an illustrated guide to diversity 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6976333
求助须知:如何正确求助?哪些是违规求助? 8655837
关于积分的说明 18351508
捐赠科研通 6436905
什么是DOI,文献DOI怎么找? 3091370
关于科研通互助平台的介绍 2146849
邀请新用户注册赠送积分活动 2067878